PEPG Stockholders With Large Losses are Encouraged to Contact Robbins LLP for Information About the Securities Class Action Laws

  • SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Robbins LLPĀ reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired PepGen Inc. (NASDAQEPG) securities between March 7, 2024 and March 3, 2025. PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.